About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Spinal Cord Reconstruction Surgery for Spinal Cord Injury
Patient Information:
Medical History and Admission:
Christopher Paul, a 21-year-old male, was admitted to Beijing Puhua International Hospital with a three-year history of movement disorder in his right leg following a previous injury.
Preoperative Evaluation:
Treatment and Intervention:
After admission, Christopher underwent spinal cord injury exploration via a posterior midline approach. Intraoperative management included fluid infusion to prevent dehydration, meticulous hemostasis, infection prophylaxis, and administration of cerebral nutrients. In conjunction with neurosurgical intervention, Neural Growth Factor Therapy was administered via lumbar puncture.
Postoperative Course and Outcome:
Following 19 days of inpatient treatment, including surgery and rehabilitation training, Christopher reported significant improvement in his mid-body and upper limb strength. The surgical wounds healed Class-A, with stitches removed successfully. Christopher expressed extreme satisfaction with the initial therapeutic response.
Conclusion:
This case describes reported changes following surgery, Neural Growth Factor Therapy and rehabilitation. It cannot establish the efficacy of any one intervention or predict results for other patients.